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Executive Summary
The rising rate of maternal mortality in the United States has received considerable federal and
state attention in recent years. 2 In response, the federal government has supported funding
and frameworks for state-created maternal mortality review committees (MMRCs). Currently,
almost every state in the union has a committee that to some extent investigates and reviews
maternal deaths.
The Centers for Disease Control and Prevention and Review to Action (a partnership between
the Association of Maternal and Child Health Programs (AMCHP) and the Enhancing Reviews
and Surveillance to Eliminate Maternal Mortality (ERASE MM) administered by the CDC)
promote the state-based maternal mortality review process and support and assist states with
extensive resources and guidance around best practices in abstracting and review. 3 Yet in
practice, collecting complete records and data related to a decedent’s care and/or death in
order to fully inform the review of the maternal death remains an identified barrier to MMRCs,
especially if the death or care occurred outside of the state in which the case is being
reviewed. 4 Many states are challenged by this issue as well as by data collection in
general. The barriers to sharing records related to maternal deaths across state lines arise, at
least in part, because maternal mortality review and data collection is governed by state statute
and each state has its own regulatory structure. The smaller New England states also have
relatively few maternal deaths as compared to more populated states, and therefore the
pathways for collection are not as familiar. Regardless, the inability of a state to obtain and
abstract comprehensive information can render a maternal mortality case unreviewable.
This report highlights barriers and strategies to records collection to support the critical
Maternal Mortality Review process.
This report is based on an extensive review of the federal regulatory landscape governing
information sharing, analysis of the Maternal Mortality Review Committee (MMRC) statutory
provisions in the New England states (ME, VT, NH, MA, RI, CT) and investigation into what might
optimize one state’s efforts to ensure reviews are not duplicated and data collection is
facilitated. The investigation included interviewing MMRC abstractors in the New England
region and in select other states where statutes appeared to allow for improved data
sharing. Reviewers were asked a key set of questions about their practices, commonly
encountered barriers to data sharing, and ways in which data sharing was facilitated either
through established technique or statutory pathways. The information was compiled, reviewed
and recommendations developed. While some states have statutes that could serve as models
for data exchange, an equally important component of data exchange is the practiced
techniques that allow for more consistent and collaborative data sharing within the existing
authority of each state statute.
Based on the investigation, the authors developed the following key recommendations to
facilitate record sharing:
•

Developing model legislative language to enhance data sharing between and among
state MMRC abstractors;
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•
•

Entering into interstate compacts and/or executing memoranda of understanding
(MOUs) between New England states that experience barriers to sharing relevant
records with one another; and
Establishing a New England Regional Collaborative in order to engage in learning
sessions among state abstractors to support consistent strategies and facilitate
mentoring and resource development.

More detailed recommendations are included in the report.

Introduction
The rising rate of maternal mortality in the United States has received considerable federal and
state attention in recent years. 5 “Maternal mortality”, as defined by the Centers for Disease
Control and Prevention (CDC), is the broad definition that encompasses the death of a woman
during pregnancy, childbirth, and the postpartum period up to a year from the end of
pregnancy. 6 MMRCs focus review and recommendations on deaths that are pregnancy-related.
The Centers for Disease Control has defined pregnancy associated deaths as follows:
“…Pregnancy-Associated Death. A death during or within one year of pregnancy,
regardless of the cause. These deaths make up the universe of maternal mortality;
within that universe are pregnancy-related deaths and pregnancy-associated, but not
related deaths.
Pregnancy-Related Death. A death during or within one year of pregnancy, from a
pregnancy complication, a chain of events initiated by pregnancy, or the aggravation of
an unrelated condition by the physiologic effects of pregnancy.
Pregnancy-Associated, but Not Related Death. A death during or within one year of
pregnancy, from a cause that is not related to pregnancy.” 7
Recognizing that standardized data collection and review is critical to better understanding the
causes of maternal mortality and eliminating preventable maternal deaths, the federal
government has supported funding and frameworks for state-created maternal mortality
review committees (MMRCs). Currently, almost every state has a committee that to some
extent investigates and reviews maternal deaths. 8
Where a death occurs does not necessarily correspond with where the decedent lived or
received medical care. 9 MMRCs are guided by the CDC Maternal Mortality Prevention Team to
review if the state is the deceased individual’s state of residence as listed on the death
certificate. Notwithstanding, the process of comprehensive review to better understand
maternal mortality necessitates collecting complete records and data related to the decedent’s
life, care and death, which process can be complicated if any occurred outside of the state
completing the review. Many states are challenged by cross-border information sharing at least
in part because maternal mortality review and data collection is governed by state statute –
and each state has its own regulatory structure and review practices. The inability of a state to
obtain and abstract comprehensive information can render a maternal mortality case
unreviewable.
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In search of strategies for effective interstate data sharing to support meaningful maternal
mortality review, the New Hampshire Maternal Mortality Team contracted with the Health Law
and Policy group at the Institute for Health Policy and Practice (IHPP). Specifically, IHPP was
asked to examine legal barriers to sharing information across state borders and identify options
to reduce barriers or leverage collaboration with other states to obtain complete records for
review of all maternal death cases.

Maternal Mortality: The Scope of a Persistent Problem
The U.S. maternal mortality rate is one of the highest among industrialized countries and has
remained high over the last two decades. 10 In 2008, the maternal mortality rate was 7.4 deaths
per 100,000 live births; by 2018, the rate had accelerated to 17.4 deaths per 100,000 live
births. 11 More than half of recorded maternal deaths occur after the day of birth. 12 Below is a
chart showing trends in pregnancy-related mortality in the United States between 1987 – 2017.
See Trends in Pregnancy-Related Deaths – CDC Pregnancy Mortality Surveillance System. 13
There are deep racial and ethnic disparities in maternal health outcomes and gaps in services,
particularly in rural areas. Pregnancy-related mortality ratios for black and American
Indian/Alaska Native women are two to three times higher than for white, Hispanic, and
Asian/Pacific Islander women. 14 Additionally, women in rural areas experience higher rates of
delayed prenatal care initiation, which increases the risk of adverse outcomes. 15 Researchers
estimate that about 66% of maternal deaths are preventable. 16
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See Trends in Pregnancy-Related Deaths – CDC Pregnancy Mortality Surveillance System, n.10.
Based on interviews with Maternal Mortality Review Committee staff, an increasing number of
maternal deaths investigated involve substance use.
NH has been experiencing approximately 10 pregnancy-associated deaths per year for the last
several years. Of these, 1 or 2 are typically categorized as pregnancy-related. While NH does
report these counts annually, the small numbers prohibit the calculation of a reliable
pregnancy-related mortality ratio. For a full analysis of New Hampshire’s maternal mortality
reviews, please see New Hampshire’s Annual Report on Maternal Mortality to NH Health and
Human Services Legislative Oversight Committee, October 23, 2020.17
Various legislation, collaboratives, systems, and reports at the state and federal level
underscore the significance of maternal mortality in the United States and the consensus that
action needs to be taken to reverse the trend.18 There are federal and state legislative and
administrative vehicles for supporting state efforts to review and identify causes of maternal
mortality. They are examined in the next section.

Federal Legislative and Regulatory Initiatives Related to Maternal Mortality
Federal Law: The Preventing Maternal Deaths Act

Congress passed the Preventing Maternal Deaths Act (the Act) at the end of 2018, which
created a federal infrastructure to support states in gathering and reviewing information about
maternal deaths. 19 The Act authorizes access to federal resources and funds for jurisdictions to
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establish new and support existing maternal mortality review committees (MMRCs). At the
time of its enactment, only thirty-six states had MMRCs and many of these were not operating
fully or optimally. 20 The Preventing Maternal Deaths Act also sets forth reporting standards
and guidance for state departments of health with respect to operating a MMRC.
According to the Act, the Secretary of the Department of Health and Human Services and
States, Indian tribes, and tribal organizations (collectively “jurisdictions”) may work together to
establish a program to support the establishment or operation of MMRCs. The Act identifies
the data to be collected and the process for review. The jurisdictions participating in the
program must “annually identify pregnancy-associated deaths and pregnancy-related deaths
through the appropriate vital statistics unit.” Doing so requires:
(I)
(II)
(III)

matching each death record related to a pregnancy-associated death or
pregnancy-related death in the State or tribal area in the applicable year to a
birth certificate of an infant or fetal death record, as applicable;
to the extent practicable, identifying an underlying or contributing cause of each
pregnancy-associated death and each pregnancy-related death in the State or
tribal area in the applicable year; and
collecting data from medical examiner and coroner reports, as appropriate[.]”

Alternatively, pregnancy-associated and pregnancy-related deaths may be identified using
other appropriate methods or information.21

ERASE MM Grant Program and Maternal Mortality Review Information
Application (MMRIA)

In 2019, the CDC announced the award of more than $45 million over the course of five years
to support the work of Maternal Mortality Review Committees (MMRC) through the Enhancing
Reviews and Surveillance to Eliminate Maternal Mortality (ERASE MM) initiative. 22
Approximately thirty-one states, including New Hampshire, are being supported through the
ERASE MM initiative. 23 As part of ERASE MM, grant awardees engage in standardized data
collection. De-identified information is then entered into the Maternal Mortality Review
Information Application (MMRIA) within two years.
MMRIA is a data system designed to facilitate MMRC functions through a common data
language and is available to all MMRCs. Standardized data collection is a critical component of
fully understanding the causes of maternal mortality and eliminating preventable maternal
deaths. MMRIA helps MMRCs organize available data and begin to comprehensively identify
and assess maternal mortality cases. MMRIA provides the following:
•
•

A repository for the collection of clinical and non-clinical information surrounding a
woman’s life and death, which can help facilitate review by a jurisdiction-based
maternal mortality review committee.
A repository for documentation of committee deliberations on:
o whether the death was related to pregnancy;
o if it could have been prevented;
o factors that contributed to the death; and
o recommendations to prevent future deaths.
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•

Standardized indicators, common to most pregnancy-related deaths that can be used
for surveillance, monitoring, and examining maternal mortality. 24

MMRIA provides an opportunity for MMRCs to achieve process requirements such as collecting
data, producing case summaries, and providing reports using robust data.25 However, MMRIA
does not facilitate sharing of identifiable information between states.26 Cases shared on
MMRIA are de-identified. A MMRIA data abstractor enters complete information onto MMRIA,
to be de-identified when shared. 27
MMRIA provides a shared data framework that empowers MMRC prevention activities. As
more MMRCs use MMRIA and are able to share de-identified data, it may be possible to:
•
•
•
•

examine the most current and the overall data;
Monitor and identify inconsistencies in decisions about pregnancy-related care to
improve or develop support tools;
Identify specific actions for prevention among all of the leading causes of pregnancyrelated death; and
Increase understanding and specificity of potential high-impact recommendations.28

Federal Surveillance Data Systems Related to Maternal Mortality

In addition to ERASE MM, there are federal surveillance data efforts that also support
monitoring maternal deaths. The CDC has two systems that collect data on maternal mortality:
Pregnancy Mortality Surveillance System (PMSS) and the National Vital Statistics System (NVSS).
Both of these systems rely heavily on death certificates. Death certificates provide the reasons
for a death through the International Classification of Diseases codes. However, there are limits
to the usefulness of this data: a death certificate does not include “diagnostic nuance,” nor can
it “communicate the interconnected stressors and system failures, often community-specific,
that contributed to a particular maternal death.” 29 The information on death certificates is too
limited to explain why an individual death occurred, preventing these national surveillance
systems from being able to answer what could be done to prevent the death in question. The
data does, however, help expose the extent of the maternal mortality problem in the United
States. Epidemiologists often can identify pregnancy-related deaths from death certificates
because states have included a “pregnancy checkbox” that allows a physician, coroner, or
medical examiner to identify that the deceased was recently pregnant.

Centers for Disease Control – Pregnancy Mortality Surveillance System

The CDC conducts national pregnancy-related death surveillance through the Pregnancy
Mortality Surveillance System (PMSS). 30 PMSS defines pregnancy-related death as “the death of
a woman while pregnant or within one year of the end of pregnancy from any cause related to
or aggravated by the pregnancy.” To collect relevant data, the CDC requests that all fifty states,
New York City, and Washington DC voluntarily send copies of death records for all pregnancyrelated deaths, linked live birth or fetal death records, and additional data when available.
Medical epidemiologists determine the cause of death and whether the death was pregnancyrelated.
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Centers for Disease Control – National Center for Health Statistics

The CDC National Center for Health Statistics maintains the National Vital Statistics System
(NVSS), which collects data on maternal deaths that occur while the woman is pregnant or
within forty-two days of the end of pregnancy, from any cause related to or aggravated by the
pregnancy or its management.31 By 2017, all states had added a standardized checkbox to their
death certificates to identify these maternal deaths, which are reported into the NVSS.

Other Federal Maternal Mortality Supports
Postpartum Medicaid Coverage

Federal law mandates that Medicaid must provide coverage to pregnant women with incomes
up to 138% of the federal poverty level; that coverage must last until 60 days postpartum. This
requirement gives Medicaid a significant role in covering births in the U.S. Medicaid covers
more than four in ten births nationally. Both Congress and state legislatures are focusing on
leveraging Medicaid’s significant role in paying for maternal care to improve it.32
Efforts to expand insurance coverage options for prenatal and postpartum women is most
recently evident in the American Rescue Plan Act of 2021, which includes an option for states to
extend an additional 12 months of Medicaid coverage to women it covered through its
pregnancy eligibility category. This option, to provide an additional year of health insurance
coverage to new mothers, is viewed as a key support to mitigating risks of maternal mortality.
This option becomes effective April 2022 and is available to states through April 2027.
Medicaid does offer other pathways to coverage for low-income mothers, but the application
of them is not universal. In states that have expanded Medicaid, women with incomes up to
138% FPL have a continued pathway to coverage. In the 12 states that have not adopted the
ACA’s Medicaid expansion, postpartum women could qualify for Medicaid as parents, however
the income eligibility for the parent category is generally much lower than the income eligibility
threshold for pregnant women in all of the states. Subsequently, the parent category cannot
provide coverage to all women who had pregnancy coverage without action by the state to
expand the income threshold of that eligibility group.

HHS Initiatives

In late 2020, the Department of Health and Human Services and the Surgeon General
announced a Call to Action and HHS Action plan to combat the high rates of pregnancy-related
complications and deaths. Concomitant to the increasing rates of pregnancy related
complications and deaths, is the disproportionate racial and ethnic disparities apparent in
maternal mortality data. Both the federal government and many states recognize the benefits
of maternal mortality review committees.

State Maternal Mortality Review Committees

The Preventing Maternal Deaths Act (the Act) further encouraged and supported state
Maternal Mortality Review Committees although some states and cities have had Maternal
Mortality Review Committees (MMRCs) for close to 100 years. MMRCs are interdisciplinary
committees that conduct reviews of maternal deaths generally occurring within one year of the
end of pregnancy. 33 Most have statewide jurisdiction, although a few cities have their own cityOctober 2021
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specific MMRC. MMRCs examine the circumstances of women’s deaths that occur during or
within one year of pregnancy, investigate why the death occurred, and identify
recommendations for preventing future deaths.
Currently more than forty states and a few cities have a formal process and committee to
review maternal deaths. These MMRCs, which are mostly created by state statute, vary in their
organizational structure and practices. There are also varying requirements for what next steps
or actions must be taken following committee review of the deaths. 34 Common locations for
MMRCs generally are in Maternal and Child Health divisions of Public Health Departments or
within a Medical Examiner’s Office. States vary as to what their MMRCs investigate and review,
including whether they review all maternal deaths that occur within the state or maternal
deaths of all residents regardless of the location of the death. See the Section on MMRC
Statutory Authorities and Appendix A for additional details on how MMRCs in New England
function.

Health Information Privacy
Federal and state requirements around maintaining privacy and confidentiality of health
information may also contribute barriers to sharing relevant maternal mortality information
across state lines. Federal privacy restrictions prohibit medical providers and certain other
entities from the unauthorized release of a patient’s medical records and health information.
Generally, the minimum protections for this information are established by the Health
Information Portability and Accountability Act (HIPAA). 35 Other federal regulations establish
greater privacy protections for certain types of records, including 42 C.F.R. Part 2 for certain
substance use disorder treatment records. States may also create more stringent protections
for individual health information. 36 To counterbalance these patient protections, privacy laws
generally include mechanisms to “allow[] the flow of health information needed to provide and
promote high quality health care and to protect the public’s health.” 37
There are laws governing every aspect of health data: collection, use, sharing, and protection.
Every transfer of health information corresponds with a decision point about what law applies
and what the law permits. These legal determinations pivot on who has the information, who
is requesting it, the nature of the information, why it was originally collected, and the
information’s intended use or purpose. An overview of relevant privacy laws can be found
below.
Understanding the federal privacy rules help to eliminate information blocking during the
MMRC abstracting process and clarification can support legal information sharing for purposes
of confidential MMRC review.

Federal Confidentiality Laws
HIPAA

The HIPAA Privacy Rule, issued by the U.S. Department of Health and Human Services to
implement the requirements of the HIPAA statute, establishes national standards for the
protection of individual health information. The Privacy Rule regulates the use and disclosure
of protected health information (PHI) by covered entities, which are organizations subject to
October 2021
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the Privacy rule. It also sets standards for the right of individuals to understand and control
how their health information is used.38 Under HIPAA, the general rule is that “[a] covered
entity or business associate may not use or disclose PHI except as permitted or required by [the
HIPAA Privacy Rule].” 39 The Privacy Rule lists the specific, permitted uses of PHI. Other uses
ordinarily require HIPAA-compliant authorization from the patient or the patient’s personal
representative.
As part of HIPAA, Congress deliberately prohibited patient privacy protections from impeding
public health activities, stating “Nothing in this part shall be construed to invalidate or limit the
authority, power, or procedures established under any law providing for the reporting of
disease or injury, child abuse, birth, or death, public health surveillance or public health
investigation or intervention.” 40
Under the Health Insurance Portability and Accountability Act (HIPAA), the Department of
Health and Human Services (HHS) has enacted regulations protecting a category of medical
information called “protected health information” (PHI). These regulations apply to health care
providers, health plans, and health care clearinghouses (covered entities), as well as certain
“business associates” of such entities. 41 The HIPAA regulations generally speak to covered
entities’: (1) use or sharing of PHI, (2) disclosure of information to consumers, (3) safeguards for
securing PHI, and (4) notification of consumers following a breach of PHI. First, with respect to
sharing, HIPAA’s privacy regulations generally prohibit covered entities from using PHI or
sharing it with third parties without patient consent unless such information is being used or
shared for treatment, payment, or “health care operations” purposes, or unless another
exception applies. 42
Reviewing the requests for information by MMRC abstractors in the context of various HIPAA
exceptions, including the public health exception, may help eliminate actual or perceived
barriers to information sharing. In addition, HIPAA does not cover de-identified information as
is generally described below.
Protected Health Information
The designation “protected health information” or “PHI” apples to all “individually identifiable
health information” held or transmitted by a covered entity or its business associate, in any
form or media including electronic, paper, or oral. “Individually identifiable health information”
includes demographic data and other information that:
•
•
•

is created or received by a health care provider, health plan, employer, or health care
clearing house; and
relates to the past, present, or future physical or mental health or condition of an
individual; the provision of health care to an individual; or the past, present, or future
payment for the provision of health care to an individual; and
that identifies the individual or can be used to identify the individual.

Various common identifiers constitute individually identifiable health information, including
name, address, birth date, and Social Security Number.
For individuals who are deceased, HIPAA continues to protect their PHI for up to 50-years post
death. Covered entities may disclose the protected health information of a deceased patient to
October 2021
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family members and others who were involved in the care or payment for care of the decedent
prior to death, unless the covered entity is aware that doing so is inconsistent with a prior
expressed preference of the individual.
Once health information has been de-identified, HIPAA does not restrict its use or disclosure.
To be considered de-identified, the information must not identify or provide a reasonable basis
to identify an individual.43 This exception is often relied upon for reporting out on maternal
deaths and can be a helpful exception for MMRC review.
HIPAA Covered Entities, Business Associates and Hybrid Entities 44
Most health care providers, whether institutions, organizations, or individuals, meet the criteria
to be classified as a covered entity. A health care provider that bills or receives payment for
health care in the normal course of business and sends covered transactions electronically is a
covered entity. Health plans and health care clearinghouses are also covered entities.
Businesses or persons that support a covered entity and access the entity’s PHI are business
associates. Like covered entities, business associates must comply with HIPAA for the PHI that it
collects, creates, uses, discloses, retains, and destroys.
Some entities that perform both covered and non-covered functions, including many state
public health departments, elect to become a hybrid entity to limit HIPAA’s application.45 A
hybrid entity must designate its “health care components,” which include “any components
that would meet the definition of a covered entity or business associate if it were a separate
legal entity.” These health care components of the hybrid are subject to HIPAA. Other “noncovered traditional public health activities, such as registries, surveillance programs and
inspection programs” are carved out from HIPAA disclosure restrictions, permitting important
data sharing to continue subject to state law.46
HIPAA Preemption
In creating HIPAA, Congress sought to establish a national framework for patient privacy that
sets a “floor” or a minimum set of individual privacy protections. 47 For this reason, the Privacy
Rule preempts only those contrary state laws relating to the privacy of individually identifiable
health information that have less stringent requirements or standards than the Privacy Rule
(i.e., more stringent laws remain in effect). In this context, “contrary” means that it is
impossible to comply with both laws or complying with the state law stands as an obstacle to
the accomplishment and execution of the Privacy Rule. “More stringent” means that the state
law provides the individual with greater rights or amounts of information or increases the
privacy protections afforded the individual.
State public health laws that permit use and disclosure of PHI for public health reasons cannot
be categorized as more stringent than HIPAA. To protect these important laws from
preemption, the Privacy Rule specifically does not preempt contrary state public health laws
that provide for the reporting of disease or injury, child abuse, birth or death, or for the
conduct of public health surveillance, investigation, or intervention.” 48 Thus, HHS may, upon
specific request from a State, determine that a provision of State law which is “contrary” to the
federal requirements, will not be preempted. Given HIPAA’s broad permission around public
health disclosures, the savings clause of the Privacy Rule will protect public health activities
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authorized by state law. This means that states should look carefully at what they need to allow
for disclosure of information for purposes of MMRC review.
Permitted Uses and Disclosures
A covered entity is permitted, but not required, to use and disclose protected health
information, without an individual’s authorization, for the following purposes or situations: (1)
to the individual (unless required for access or accounting of disclosures); (2) treatment,
payment, and health care operations; (3) opportunity to agree or object; (4) incident to an
otherwise permitted use and disclosure; (5) public Interest and benefit activities; and (6) limited
data set for the purposes of research, public health or health care operations. 49 Covered
entities may rely on professional ethics and best judgments in deciding which of these
permissive uses and disclosures to make. 50
The Privacy Rule generally requires covered entities to take reasonable steps to limit the use or
disclosure of, and requests for, protected health information to the minimum necessary to
accomplish the intended purpose. The minimum necessary standard does not apply to certain
disclosures, however, including disclosures to a health care provider for treatment purposes,
disclosures to the individual who is the subject of the information, and disclosures that are
required by law.
The exceptions to HIPAA allow for uses and disclosures of PHI that are broader than allowed by
the savings clause. 51 In light of the goals of this project to better understand how cross-border
information sharing may be improved for purposes of maternal mortality case reviews, the
forthcoming sections focus on permitted uses and disclosures for public interest and benefit
activities and the limited data set.
Public Interest and Benefit Activities Required by Law 52
The Privacy Rule permits a covered entity to disclose PHI without the authorization of the
individual when the disclosure is required by law and the disclosure complies with the
requirements of that law. When a disclosure is required by law, the Privacy Rule’s minimum
necessary standard does not apply. The law requiring the disclosure will establish limitations
around what should be disclosed. A covered entity cannot point to the Privacy Rule as a basis
for not complying with a disclosure that is required by law.53
Public Health Activity
HIPAA recognizes that public health authorities and others responsible for ensuring public
health and safety have a legitimate need to access protected health information. To protect
this legitimate need, the Privacy Rule permits covered entities to disclose PHI without
authorization to a public health authority that is authorized by law to receive such reports for
the purpose of preventing or controlling disease, injury, or disability. This includes the reporting
of a disease or injury, reporting vital events such as births or deaths, and conducting public
health surveillance, investigations, or interventions. 54
A public health authority is defined as an agency or authority of the United States, a State, a
territory, a political subdivision of a State or territory, or an Indian tribe. The definition also
extends to a person or entity acting under a grant of authority from or contract with such public
agency. 55 In addition to being a public health authority, the entity seeking the information must
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also be “authorized by law” to receive it. This requirement is satisfied when there is a legal basis
for the activity; it does not require a specific law authorizing the collection of the information
requested. 56 Covered entities are not required to make a minimum necessary determination for
public health disclosures that are required by other law. Covered entities that are also a public
health authority may use, and disclose, protected health information consistent with laws,
regulations, and policies applicable to the public health authority. 57
In most states queried for this report, the barriers to disclosure of individually identifiable
health information were not due to HIPAA privacy rules, but to more restrictive state laws
governing confidentiality of such information, or, in some cases, a perception that such
restrictions would apply. The HIPAA privacy rule preempts contrary state laws, but not if the
state law provides greater privacy protections to such information, making the potential HIPAA
public health exception pathway unavailable in some states.
Limited Data Sets
A limited data set is PHI with most, but not all, identifiers removed. The Privacy Rule lists
sixteen direct identifiers that may not be included in a limited data set, but permits the
inclusion of dates of admission, discharge and service; dates of birth and death; and geographic
information (except street address), among others. Limited data sets may be disclosed for
research, public health, or health care operations purposes and must be accompanied by a data
use agreement.
Research on Decedents
To use or disclose PHI of the deceased for research, covered entities are not required to obtain
authorizations from the personal representative or next of kin, a waiver or an alteration of the
authorization, or a data use agreement. However, the covered entity must obtain from the
researcher who is seeking access to decedents' PHI (1) oral or written representations that the
use and disclosure is sought solely for research on the PHI of decedents, (2) oral or written
representations that the PHI for which use or disclosure is sought is necessary for the research
purposes, and (3) documentation, at the request of the covered entity, of the death of the
individuals whose PHI is sought by the researchers.

Substance Use Disorder Treatment Records (42 CFR Part 2)

Federal law, regulated by SAMHSA and 42 CFR Part 2 (“Part 2”) also protects the privacy of
those who seek evaluation or treatment for substance use disorders from federally assisted
programs, known as “Part 2 programs.” Generally, Part 2 requires a patient’s written consent
before disclosing the identity of the patient and any protected treatment records. Part 2 also
recognizes a few limited exceptions when providers can make disclosures without a patient’s
written consent, such as for government program audit, research or in an emergency. Unlike
HIPAA, Part 2 does not include an exception for disclosures to a public health authority or
disclosures required by law. Providing information to a maternal mortality review commission
does not appear to fall squarely within one of the exceptions, as described in further detail
below, but upcoming changes to Part 2 implemented by the Coronavirus Aid, Relief, and
Economic Security Act (CARES Act) may change this. 58
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Audits and Evaluations
A Part 2 program may disclose Part 2 data for activities undertaken by a federal, state, or local
governmental agency or third-party payer to identify needed actions to improve the delivery of
care, to manage resources effectively to care for patients, or to determine the need for
adjustments to payment policies to enhance care or coverage for patients with SUD. The final
rule clarifies that governmental agencies and third-party payers may conduct audits and
evaluations to identify necessary actions at the agency or payer level to improve care. This
includes reviews of appropriateness of medical care, medical necessity and utilization of
services by auditors that may include quality assurance organizations as well as entities with
direct administrative control over a Part 2 program. The final rule removes the word “periodic”
so as not to indicate the frequency with which audit and evaluation activities should occur.
Research
The final rule permits disclosure of SUD Records by a Health Insurance Portability and
Accountability Act (HIPAA) covered entity or business associate to individuals/organizations
who are not subject to HIPAA’s privacy rule or the HHS regulations regarding the protection of
human subjects, known as the Common Rule, for the purpose of conducting scientific research.
The final rule seeks to align Part 2, the Common Rule and the Privacy Rule for the conduct of
research on human subjects, and to streamline duplicative requirements for research
disclosures under Part 2 and the privacy rule. It also permits research disclosures to recipients
covered by FDA regulations for the protection of human subjects in clinical investigations.

Preventing Maternal Deaths Act 59

As noted previously, the Preventing Maternal Deaths Act of 2018 (HR 1318), signed into law
December 21, 2018, established a system for assessing maternal deaths by setting up a federal
infrastructure and allocating resources to collect and analyze data on every maternal death in
every state. The Act supports MMRCs through federal funding and reporting of standardized
data.
The Act requires that Maternal Mortality Review Committees established by participating states
use best practices in their methods and processes for data collection and review of all
pregnancy-associated deaths and pregnancy-related deaths, regardless of the outcome of the
pregnancy. Id.
More specifically, in addition to prescribing conditions for participation as a Maternal Mortality
Review Committee, the Act establishes a process for confidential reporting and data collection:
(Section 317K of the Public Health Service Act (42 U.S.C. 247b– 12) (d)(2))
Process for confidential reporting.--States, Indian tribes, and tribal organizations that
participate in the program described in this subsection shall, through the State maternal
mortality review committee, develop a process that—
(A) provides for confidential case reporting of pregnancy-associated and pregnancyrelated deaths to the appropriate State or tribal health agency, including such reporting
by—(i) health care professionals;(ii) health care facilities; (iii) any individual responsible
for completing death records, including medical examiners and medical coroners; and
(iv) other appropriate individuals or entities; and
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(B) provides for voluntary and confidential case reporting of pregnancy-associated
deaths and pregnancy- related deaths to the appropriate State or tribal health agency
by family members of the deceased, and other appropriate individuals, for purposes of
review by the applicable maternal mortality review committee; and
(C) shall include—(i) … making publicly available contact information of the committee
for use in such reporting; and (ii) conducting outreach to local professional
organizations, community organizations, and social services agencies regarding the
availability of the review committee.
(3) Data collection and review.--States, Indian tribes, and tribal organizations that
participate in the program described in this subsection shall-(A) annually identify pregnancy-associated deaths and pregnancy-related deaths-- (i)
through the appropriate vital statistics unit by-- (I) matching each death record related
to a pregnancy-associated death or pregnancy-related death in the State or tribal area in
the applicable year to a birth certificate of an infant or fetal death record, as applicable;
(II) to the extent practicable, identifying an underlying or contributing cause of each
pregnancy-associated death and each pregnancy-related death in the State or tribal
area in the applicable year; and (III) collecting data from medical examiner and coroner
reports, as appropriate; (ii) using other appropriate methods or information to identify
pregnancy-associated deaths and pregnancy-related deaths, including deaths from
pregnancy outcomes not identified through clause (i)(I);
The Preventing Maternal Deaths Act requires jurisdictions participating in the program to
establish minimum confidentiality protections prohibiting disclosure, including to any
government official, of any identifying information about any specific maternal mortality case
by the maternal mortality review committee. The protections also forbid making public any
information from committee proceedings, including deliberation or records, unless specifically
authorized by state or federal law.

State Law Confidentiality: MMRC Statutory Authorities

States vary significantly in their MMRC processes and approaches to maintaining the
confidentiality of personal health information. An overview of the MMRC legal authorities of
the New England states, with a focus on their authorities and practices to obtain relevant
records is described below and set forth in greater detail in Appendix A. Most New England
states’ MMRCs are created and defined by state statute.

New Hampshire

New Hampshire’s maternal mortality review panel conducts comprehensive, multidisciplinary
reviews of “maternal deaths in New Hampshire for the purpose of identifying factors associated
with the deaths and to make recommendations for system changes to improve services” for
New Hampshire women. 60 Health care providers, health care facilities, and state agencies are
among those required to report maternal mortality deaths.
Before the panel receives information to complete its review, records are deidentified. Either
New Hampshire’s Department of Health and Human Services or, at the direction of the
Commissioner, the Northern New England Perinatal Quality Improvement Network (NNEPQIN)
will collect and analyze records. 61 By statute, the types of case information that may be
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collected include vital records; hospital discharge data; prenatal, fetal, pediatric, or infant
medical records; hospital or clinic records; laboratory reports; records of fetal deaths or
induced terminations of pregnancies; and autopsy reports. 62 This same case information may
be acquired from health care facilities, maternal mortality review programs, and other sources
in other states as needed for accurate and complete information. The family of the deceased
woman may also be contacted for a discussion of the events surrounding the death.
Each year the Commissioner must issue a report describing the adverse events reviewed by the
panel, outlining corrective action plans, and making recommendations for system change and
legislation. Each member of the multidisciplinary panel is required to disseminate panel
recommendations to his or her respective institutions and professional organizations through
the quality assurance programs to protect confidentiality.
All proceedings, records, and opinions of the panel are confidential and not subject to RSA 91A, which means the public cannot make a public records request or access the information
collected by or shared from the MMRC even through discovery in civil or criminal proceedings.
In addition, members can’t be questioned in any civil or criminal proceeding regarding
information presented or opinions formed as a result of a meeting of the MMRC team.

Massachusetts

Massachusetts has in place a general statute permitting the Commissioner of the Department
of Public Health (DPH) to “authorize or cause to be made scientific studies and research which
have for their purpose the reduction of morbidity and mortality within the commonwealth.”
Under this statute’s legal authority, the Commissioner of Public Health has approved the
Maternal Mortality and Morbidity Review Committee to proceed using confidential
Massachusetts DPH state-wide data.
The Massachusetts MMRC committee has been approved, essentially, to conduct a research
study into maternal deaths, with strict confidentiality guidelines and limitations on use.
“The Research and Data Access Review (RaDAR) Committee has approved [249885-1]
the Pregnancy-associated Mortality and Morbidity Review Study, and authorizes you to
conduct that study using confidential Massachusetts Department of Public Health
(MDPH) data in accordance with M.G.L. c. 111,§24A.Please note that any research study
to be conducted as a result of the Maternal Mortality and Morbidity Review
Committee's work and the use of MDPH confidential information will require MDPH IRB
review and approval prior to proceeding.” 63
All information obtained in connection with the Committee “shall be confidential and shall be
used solely for the purposes of medical or scientific research.” No one participating in an
authorized study or research project may disclose any information obtained, except in strict
conformity with the research project.64 Historically, Massachusetts has been able to collaborate
with outside institutions on research studies, but not investigations.
In January 2021, Massachusetts’ Governor Baker signed An Act to Reduce Racial Inequities in
Maternal Health, which created a special legislative commission to investigate and study
methods to reduce racial inequities in maternal health. Part of the commission’s mandate will
be to investigate and study “the availability of data collected by the commonwealth and the
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Massachusetts Maternal Mortality and Morbidity Review Committee, including outpatient data
and what additional data may be needed.” 65 Massachusetts hospitals are required to report
the death of a pregnant woman during pregnancy or within 90 days of delivery or termination
of pregnancy. 66

Vermont

The Vermont Maternal Mortality Review Panel reviews maternal deaths in Vermont to identify
factors associated with the deaths and make recommendations for system changes to improve
health care services for women in Vermont.
As in New Hampshire, the Vermont Commissioner of Health may delegate the functions of
collecting, analyzing, and disseminating maternal mortality information to NNEPQIN.
Vermont’s statute was recently amended to expressly reference cross-border information
sharing as part of its maternal mortality review process. Pursuant to the new language,
Vermont “may enter into reciprocal agreements with other states that have maternal mortality
review panels provided access under such agreements is consistent with privacy, security, and
disclosure protections in this chapter.” 67 It may also acquire records from “health care
facilities, maternal mortality review programs, and other sources in other states to ensure that
the Panel’s records of Vermont maternal mortality cases are accurate and complete.” 68
Vermont’s reciprocity language may be worth considering as a model. In practice, Vermont has
not relied yet on the reciprocity provisions partly because Vermont has very few maternal
deaths to investigate.

Maine

In 2020, Maine’s Maternal, Fetal and Infant Mortality Review (MFIMR) Panel expanded the
scope of maternal deaths it reviews, changing from “a woman who died during pregnancy or
within 42 days of giving birth” to one “who died during pregnancy or within one year of giving
birth.” 69 The statutory change also removed the requirement that the investigator proceed with
the investigation only after a four-month waiting period from the date of the death together
with obtaining the permission of the decedent’s family to investigate.
The new statute grants the panel coordinator authority to access the health care information of
the deceased and permits the panel to request and review data from another state review
panel. The panel must create an annual report identifying factors contributing to maternal,
fetal and infant mortality in the state, determine the strengths and weaknesses of the maternal
and infant health care delivery system and make recommendations to decrease the rate of
maternal, fetal and infant mortality.
MFIMR reviews maternal deaths that occur in Maine, together with fetal and infant deaths. It
gathers health care records by submitting a written request to the provider together with a
copy of the state statute that outlines its legal authority to seek information and conduct
investigations. Maine relies on vital records and health care records of the decedent to identify
healthcare providers of the decedent. The linked birth records, which includes birth hospital
and location of parent, is helpful. The panel reviews ten or fewer maternal deaths annually and
could not identify an instance in which out-of-state care was provided and subsequently, no
out-of-state records were needed.
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Connecticut

Connecticut has a maternal mortality review committee within the Department of Public Health
to “conduct a comprehensive, multidisciplinary review of maternal deaths for purposes of
identifying factors associated with maternal death and making recommendations to reduce
maternal deaths.” 70 The statute outlines that the committee is responsible for identifying
maternal deaths in Connecticut and reviewing medical records and other relevant data.71 The
information reviewed may be used “solely for the purpose of medical or scientific research,”
and may be exchanged for this purpose with “any other governmental agency or private
research organization.” 72
Connecticut’s MMRC investigates maternal deaths of Connecticut residents regardless of the
location of the death. To obtain relevant records, similar to Rhode Island and Maine, the
investigator sends the request for records together with a copy of the statute that outlines its
legal authority to seek information and conduct investigations. Similar to Maine, Connecticut
relies heavily on vital records – including death certificates and medical examiners reports together with health care records. Linked birth records - including the name of the birth
hospital – are frequently included with the other vital records information and offers another
avenue for locating additional health care provider of the decedent.
Connecticut is able to share its vital records information with other states, but not all states
have reciprocal authority. Connecticut’s MMRC panel reviews 15-20 maternal deaths annually.
To the extent Connecticut identifies an out-of-state maternal death or out-of-state care
provided to a relevant decedent, it relies on calling the provider and explaining the
circumstances in order to obtain the relevant records. Connecticut staff reflected that its state
statute likely would not be binding on another jurisdiction. Subsequently, it prioritized
relationships and telephone contact as a way to obtain records in a context in which no legal
obligation to produce the record existed.

Rhode Island

Rhode Island codified its maternal mortality review committee as its Pregnancy and Postpartum
Death Review Committee (PPDRC) in 2019, making the office of the state medical examiner
responsible for a “multidisciplinary maternal mortality review committee for review of
maternal deaths.” The committee has the authority to request and receive data from vital
records, healthcare providers, healthcare facilities, pharmacy records, and other agencies or
officials having information that is necessary for the committee to carry out its duties. The
committee must develop recommendations for the prevention of maternal deaths and
disseminate findings and recommendations to policy makers, healthcare providers, healthcare
facilities, and the general public. 73
Rhode Island, similar to Connecticut and Maine, obtains relevant records by sending a request
form from the Medical Examiners’ Office citing the statutory language that authorizes PPDRCs
to seek records for investigation of maternal deaths.
Rhode Island also frequently links the name of the birth hospital to the vital records of the
decedent, providing another route for identifying relevant health care providers. To the extent
Rhode Island identifies an out-of-state maternal death or out-of-state care provided to a

October 2021

©2021 Institute for Health Policy and Practice, UNH. All Rights Reserved

- 21 -

relevant decedent, it relies on calling the provider and explaining the circumstances in order to
receive the relevant records.
Rhode Island staff reflected that being persistent and friendly were among the most effective
tools for obtaining health care records from all providers. Staff also reflected that the most
time-consuming component of investigations was combing through records to identify relevant
providers. Rhode Island anticipates there will be 10-15 annual deaths for the PPDRC to review.

Barriers to Cross-Border Information Sharing
There are barriers and common challenges to cross border sharing of maternal death records
and to data collection in general. Some of the key barriers include:
•

•
•
•
•
•
•
•

Lack of explicit statutory authority authorizing one state to share vital records with
other states even on behalf of MMRC or a lack of awareness of pathways such as
interjurisdictional agreements (e.g., State and Territorial Exchange of Vital Records
or STEVE);
Lack of explicit statutory or other authority for one state MMRC to share
protected health or other private information with a cross-border state MMRC;
Lack of explicit requirement for providers to share records following any MMRC
request or maternal death;
Small number of maternal deaths in New England states and inconsistent
treatment of SUD, traffic accidents, mental health conditions as relevant to MMRC
activities.
Under-developed process for requesting and obtaining records directly from
providers; and
Lack of familiarity with other regional MMRC abstractors to share contacts and
“tips” regarding their state’s information and access;
Varying experience/background of abstractors;
Uncertainty about legal authority to ask for or share information.

The multiple federal and state laws protecting certain types of information from disclosure or
that govern access create actual or perceived barriers to data sharing for purposes of maternal
mortality review. Consistent barriers to cross-border information sharing include narrowly
tailored statutes lacking explicit clarity around data sharing, small numbers of maternal
mortality cases in New England states, inconsistent treatment of pregnancy-associated deaths,
relatively new MMRC programs and abstractors and under-developed processes for requesting
and obtaining records. The information and learning opportunities made available through the
CDC have helped to make the review process more consistent amongst states, however, more
regional learning collaboratives focused on information access could help to alleviate barriers.

Lack of Statutory Authority

In assessing the barriers within the MMRC statutes, it’s important to review whether the
statute allows the states MMRC authority to collect any and all information necessary to
conduct the review.
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Narrowly tailored MMRC statutes limit the ability of MMRCs to collect important information.
While most MMRC statutes authorize collection in the home state, there are few statutes that
explicitly authorize one MMRC to share information with a review committee in another state
or engage directly in records exchanges. That said, the state MMRC statutes do not typically
bind providers or prohibit a provider from making records available to a cross-border MMRC.
The MMRC statutes in New England, with the exception of the Massachusetts statute, provide
clear authority to conduct maternal mortality review activities for public health purposes, which
technically may be sufficient to satisfy the public health exception to the HIPAA privacy rule and
support improved information access. 74 However, state entities are often reluctant to act
without explicit state statutory authority to do so and many may be unfamiliar with the public
health exception to the HIPAA privacy rule. This may inhibit MMRCs from relying on the HIPAA
public health exception to disclose records across state lines with other state MMRCs. This
same dynamic may inhibit individual providers from sharing records across states, although, as
noted above, while the MMRC may be limited, the provider, as a HIPAA entity, should provide
records upon request to MMRCs.
While the MMRC statutes in New England provide authority for MMRCs to obtain records from
providers within their home states, the statutes do not extend the requirement that providers
share requested relevant records or data to MMRCs outside of the state. That said, providers
are authorized under HIPAA to provide to a public health authority and for purposes of MMRC
activities
More importantly, most New England states do not generally have language explicitly allowing
states MMRCs or other state entities to share identifiable health data for public health
purposes, therefore limiting what an abstractor in one state could share with an abstractor in
another state, or what an abstractor in one state could obtain from state entities. Only
Connecticut has a statute that explicitly permits the state to share identifiable health data with
other states upon request for public health purposes. This provision enables Connecticut to
share its vital records, including birth and death certificates, which are often central to the
MMRC abstractor identifying where and what type of care the decedent received.
Vermont’s MMRC statute permits the MMRC to enter into a reciprocal data sharing agreement
with another MMRC. However, no other New England state has explicit language permitting it
to enter into an MMRC data sharing reciprocal agreement, which leaves Vermont without a
data sharing partner.

Small Numbers of Maternal Mortality Cases in the Region

The small number of maternal mortality cases impacts the information sharing. State MMRCs
report inconsistent treatment of pregnancy-associated deaths, lack of funding and resources to
support thorough reviews, and relatively new MMRC programs.
The estimated number of maternal deaths to be annually reviewed by the New England states
were very low, ranging from 2 to 20 per state. While anecdotal, some abstractors noted that
the involvement of opioids or other substances in the deaths makes the abstracting more
difficult.
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Some states did not expect to pursue comprehensive reviews of maternal deaths associated
with traffic accidents or complications from addiction, as those incidents were construed as
being outside of the intended focus of the review. This narrower focus likely further reduces
the number of maternal mortality reviews. The low number of cases to review ultimately
results in less need to request and obtain relevant records, both in state and out of state. At
the time of the state interviews, many of the MMRC programs and staff were relatively new
and still learning how to define the scope of their review, conduct an investigation, develop an
abstract, effectively request and obtain needed records, and prepare the cases for the
committee review.
While states have had issues collecting cross-border information, the barriers presented by
cross-border sharing do not overwhelm other immediate barriers to review, such as staffing,
resources and experience. Whether or not a state prioritizes review is also a key indicator of
success.

Recommendations for Improved Cross-Border Information Sharing
To be effective, any information sharing approach adopted should be minimally burdensome,
flexible, and have clear guidelines. Clear communication identifying the legal authority to
share the information, together with persistent follow up, may help facilitate information
sharing in the absence of changes to statutory language. All states, including New Hampshire,
have multiple panels, commissions, and committees with the authority to investigate and
review information on death, disease or other public health concerns. For example, these
various panels are tasked with investigating child fatality, domestic abuse, drug overdose,
incapacitated adults, birth defects, and rare disease. Follow up with some of these entities may
be useful for identifying additional potential solutions to cross-border information sharing
beyond those shared below.

Consistent Authorizing Legislation to Preserve Confidentiality While Allowing for
Cross-Border Exchange for MMRC:
•
•
•
•
•

MMRC legislation should clarify that MMRC has access to vital records both within the state
and for deaths outside the state to ensure no barriers to vital records access exist;
MMRC legislation should specify all state health care providers must share requested
records with any maternal mortality review committee request from any state, for public
health purposes;
MMRC legislation should clarify that MMRC abstractor may request and obtain information
from other jurisdictions in order to have complete information about maternal mortality in
home state;
MMRC legislation should specify that MMRC may enter into memoranda of understanding
with other MMRCs to facilitate comprehensive data collection;
MMRC legislation should state that the maternal mortality review committee is a public
health authority conducting public health activities pursuant to the federal Health Insurance
Portability and Accountability Act (HIPAA) (42 U.S.C. § 1320d et seq.);
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•

Create interstate compacts around data collection for MMRCs to set forth common
practices, agreements and protocols for confidential cross-border data sharing for MMRC
purposes.

Statutory Changes: Model Legislation/Uniform Laws

While many of the state statutes authorizing the MMRCs may be sufficient to satisfy the HIPAA
public health exception to the privacy rule, state entities may be reluctant to share information
without explicit legal authority to do so in state statute. Having the following provisions
explicitly in statute will facilitate sharing relevant MMRC data and records across state lines:
•
•
•
•
•

authorize the state to share identifiable health information, including births and deaths,
upon request with other states for public health purposes including reducing mortality
and morbidity from all causes;
direct all health care providers to share requested records with regional maternal
mortality review committee requests for public health purposes;
specify that the maternal mortality review committee may request, obtain and review
information from other jurisdictions in order to have complete maternal mortality data;
specify that the MMRC may enter into memoranda of understanding with other MMRCs
to facilitate comprehensive data collection;
amplify that the maternal mortality review committee and its staff is a public health
authority conducting public health activities pursuant to the federal Health Insurance
Portability and Accountability Act (HIPAA) (42 U.S.C. § 1320d et seq.)

Interstate Compact

Interstate compacts or memoranda of understanding are a tool used by state governments
regionally or nationally to promote and insure cooperative action among the states. They are
state-developed and act as a formal agreement between states. Compacts have the
characteristics of both a statute and a contract. Typically, each state legislature will adopt
identical statutory language, using the interstate compact to:
•
•
•
•
•
•
•

Establish a formal, legal relationship among states to address common problems
or promote a common agenda;
Create independent, multistate governmental authorities (e.g., commissions)
that can address issues more effectively than a state agency acting
independently, or when no state has the authority to act unilaterally;
Establish uniform guidelines, standards, or procedures for agencies in the
compact’s member states;
Create economies of scale to reduce administrative and other costs;
Respond to national priorities in consultation or partnership with the federal
government;
Retain state sovereignty in matters traditionally reserved for the states; and
Settle interstate disputes. 75

Interstate compact negotiation is usually done at the direction of the governor by the
governor’s appointee. Once an initial agreement is reached, it must be enacted by the
legislature. Certain interstate compacts, those that are “directed to the formation of any
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combination tending to the increase of political power in the States, which may encroach upon
or interfere with the just supremacy of the United States” must receive the consent of
Congress. 76 Compacts that are approved by Congress also become federal law.
New Hampshire is a member of several compacts, including the Nurse Licensure Compact,
National Crime Prevention and Privacy Compact, the Interstate Compact for the Supervision of
Adult Offenders, among others. 77 The Nurse Licensure Compact allows a nurse to practice in
states that are part of the compact without obtaining a separate nursing license in each state.
The Nurse Licensure Compact has purposes other than data sharing, but it is one example of a
compact that facilitates the transmission of confidential data between states. As part of the
Nurse Licensure Compact, states can share information about confidential complaint
investigations. Typically, the nurse’s state of residence (“home state”) and the state where the
incident forming the basis of the complaint occurred, also known as the remote state, will
communicate, with the remote state taking the lead in conducting the investigation because it
will have easier access to investigative records and witnesses. Once the investigation is
complete, the investigative information is transmitted to the home state for consideration of
disciplinary action against the nurse’s license, which will affect the nurse’s practice in all
compact states. A remote state may, based on the same complaint investigation, impose other
restrictions on the privilege to practice in the remote state. Licensure, discipline, and practice
privileges are recorded in Nursys, a national database. 78 An MMRC interstate compact could
work in the same manner, allowing all participating MMRCs to transmit information relevant to
MMRC investigations to other states without additional legal authority.
As an alternative to the more formal “compact”, states could enter into Memoranda of
Understanding regarding shared protocols and practices for enhanced information sharing
consistent with each state’s statutory authority.

Establish a New England Regional MMRC Collaborative

The New England states (Maine, Vermont, New Hampshire, Massachusetts, Rhode Island and
Connecticut) should establish a robust New England Regional MMRC Collaborative. Beyond
explicit statutory changes, the New England state MMRCs could enhance cross-border data
sharing by cultivating best practices and protocols amongst the states and the state MMRC
abstractors in order to:
•
•
•
•
•

Meet consistently to share best practices and common barriers;
Develop roster of Abstractors and list serve amongst NE states;
Pursue Interstate Compacts or Memoranda of Understanding to facilitate data
exchange;
Leverage relationship with other MMRC abstractor to facilitate relationship /requests
with out of state providers or out of state vital records holders;
Share information about evidenced based indicators impacting maternal mortality and
policy options to address.

A New England MMRC would require the 6 new England states MMRC staff meeting regularly
to share best practices, common barriers and potential opportunities to formally allow record
or data sharing. MMRC staff in other regions of the country noted that they know their MMRC
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counterparts in border states and that relationship can be useful in obtaining needed records.
One abstractor provided an example in which she indirectly facilitated obtaining out-of- state
records from an out-of-state provider because her MMRC border state counterpart made a
provider aware of her relationship with the in-state MMRC abstractor. Establishing a common
connection and purpose provided context for the provider, who was familiar with the in-state
MMRC abstractor and understood the need for the request. This aided in an expediated receipt
of records for the out-of-state MMRC abstractor.

Develop Consistent Record Request Pathways and Learning Collaborative/Tools
to Support Protocols
Summary

Interviews with MMRC abstractors highlighted the need for a more robust learning opportunity
amongst the states to allow for refined and evidenced based processes and practices for
obtaining records directly from providers and agencies both in-state and cross-borders. Some of
the recommendations that manifest from the detailed conversations with the state abstractors
include the following:
•
•
•
•
•
•
•
•

Consistent written requests, citing statutory authority of MMRC together with
request for specific records (form letters are available from states);
Share written request templates with cross-border abstractors and include
reference to cross-border state MMRC or other helpful authority;
Seek assistance from cross-border state abstractor around difficulties presented
by cross-border state providers or regulators;
Amplify exceptions of “required by law” and “public health activity” to HIPAA
privacy rule;
Plan and prepare to follow-up written requests with multiple phone calls;
Create familiarity of MMRC purpose and process with providers, labs, vital records,
any holder of relevant records;
Use Abstractor Manual to explain different processes for requesting required
records; and
Develop inserts or updates to Abstractor Manual on case studies and other
experienced based strategies.

The concept of creating or using MMRIA as a type of health information exchange is worth
pursuing, however, it would only be as good as the inputs. There are many circumstances
where technology might not solve the information barriers. During the research for this report,
abstractors in states where information is effectively exchanged across-borders reported they
were most successful at completing their abstracts when they relied on a variety of techniques
to investigate the mother’s history and contacts, both clinical and social. After investigating the
clinical and social history, the abstractors targeted the providers or entities with records
requests and follow-up either in-state or out-of-state using channels of communication often
already established (e.g., familiarity with medical records staff at large hospital system). The
abstractors often found that the in-state providers had out-of-state records in their files
already. More importantly, the abstractors mapped out what records they needed, and who
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they needed to request them from, often seeking the help of out-of-state abstractors to trouble
shoot best strategies.
Much of the information obtained by abstractors from other states came directly from sources,
and not through the out-of-state abstractors. Technology that enabled abstractors to access
records through a Health Information Exchange from states who host them, or communicate
more effectively with other abstractors through a MMRIA messaging system, might be
productive.

Abstractor Techniques and Experiences

The abstractors who shared their
history and successful experiences,
Abstractor
State 1
recounted a number of different
strategies and techniques to obtain
records. MMRC abstractors frequently
utilize a common process. They send a
form letter requesting particular
Entity State 2
Abstractor State 2
records to a provider or entity,
attaching a reference to and specific
language from the enabling state
statute providing the MMRC's authority
Provider
to seek and obtain records. MMRC staff
State 2
acknowledged that while out-of-state
providers aren’t subject to in-state laws,
they felt it was helpful to share their
legal authority and responsibilities with the out of state provider and they often complied.
MMRC staff plan for and follow up on the written request with phone calls.
The success of the MMRC abstractors seemed to depend upon their clinical experience and
familiarity with key staff at organizations who typically provide necessary records. Many of the
abstractors rely on long established lines of communication developed by prior abstractors.
Many were able to use the credibility and purpose of the MMRC process as well as education to
assist.
Educating providers and other entities about the MMRC process and familiarizing key staff with
the MMRC abstractor and purpose of the program facilitated receiving requested records.
Certainly, the abstractors who are required to promptly perform the abstract are able to
streamline the process, especially in states with higher mortality rates. Even if an abstractor
initially had difficulty obtaining out-of-state records, once providers and medical record keepers
became familiar with the MMRC purpose and staff, they generally willingly complied with
records requests. MMRC staff may want to consider a mechanism to formally introduce the
MMRC program and staff to providers and state agencies in order to facilitate sharing of
records.
Highlighting the authority the state has vested in the MMRC to investigate maternal deaths
together with building familiarity and relationships with those who hold relevant records can be
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an effective combination to facilitate information sharing. More importantly, each abstractor
has, over time and with practice, developed strategies to facilitate the collection of necessary
information all of which would be helpful to share in order to map out best practices in action
for other abstractors.

Enhanced Abstractor Manual

The Review to Action framework has produced a Maternal Mortality Review Committee
Abstractor Manual for use by abstractors to help them with both a clinical understanding of
issues as well as processes for identifying necessary data and information. 79 The Manual is
helpful and highlights what type of records provide important sources of data and information:
•

•

•
•
•
•
•
•

Vital statistics: death certificates, birth certificates, fetal death records
o Information on death certificate provides demographic information and
descriptive information on cause, place, and time of death.
o Examples of information on a standard infant birth certificate include:
demographic information on mother and father, prenatal care entry, number of
visits, birth weight, Apgar scores, gestational age, complications, and name of
birth hospital.
Prenatal records:
o These records are typically sent by 36 weeks to the delivery facility; therefore,
end of pregnancy visits may be missing.
o You may need to request full records or make an on-site visit to the prenatal
clinic.
Hospital records: including all outpatient and inpatient stays during terminal
pregnancy/postpartum period, and notes on social services
Outpatient clinic records: preconception/family planning clinics, primary care, abortion
centers
Autopsy reports and case findings from hospital, coroner, or other medical examiner
Police/investigative reports
Medical transport records including timing, notes, vitals, treatments
Personal interviews with providers, family, or friends

The Manual also provides brief tips on ensuring the MMRC and abstractor know their
responsibilities and authorities, drafting appropriate letters to providers and entities in order to
collect necessary data, making contact with entities who have important information, being a
“squeaky wheel” to get the abstraction done (for example, placing follow up calls, getting
names and phone numbers, using contacts of members of the MMRC, patients, sensitivity,
persistence, and documentation of unsuccessful attempts in order to problem solve solutions
with MMRC. Id. at pp. 15-18.
Despite these tips, there is significant anecdotal information from the many New England
abstractors that demonstrates the “how to” information, guidance, and “work shop” could
include significant addition ideas, methodologies and case studies to allow for true consistency
and success. In addition, each state, each agency, each provider present special barriers, which
in-person learning could help to solve and resolve.

October 2021

©2021 Institute for Health Policy and Practice, UNH. All Rights Reserved

- 29 -

Conclusion
A widely recognized and critical barrier to identifying and investigating maternal deaths is the
collection of complete data when care for the mother was provided outside of the state in
which the maternal death occurred or in the instance in which the mother’s death occurred
outside her state of residence. Many states are challenged by this issue, including those in New
England. Maternal mortality review and data collection is governed by state statute, which
results in different governance structures, priorities and regulations amongst the states,
creating barriers to sharing records between them. The inability of an abstractor in one state to
obtain and abstract relevant information from another state or from within can render a
maternal mortality case unreviewable.
This report is based on an extensive review of the federal regulatory landscape, analysis of the
Maternal Mortality Review Committee (MMRC) statutory provisions in the New England states
(ME, VT, NH, MA, RI, CT) and investigation into what might optimize one state’s efforts to
ensure reviews are not duplicated and data collection is facilitated. The investigation included
interviewing MMRC abstractors in the New England region and in select other states where
statutes appeared to allow for improved data sharing. Reviewers were asked a key set of
questions about their practices, commonly encountered barriers to data sharing, and ways in
which data sharing was facilitated either through technique or statutory pathways. The
information was compiled, reviewed and recommendations developed.
The abstractor interviews provided a detailed view into the barriers and revealed the need to
ensure consistent learning opportunities to share best practices amongst abstractors. Many
abstractors who performed numerous abstracts over time developed innovative and practiced
ways to ensure data could be secured both from in-state and from out-of-state
providers. While some states have statutes that could serve as models for data exchange and
authority, an equally important component is the practiced techniques to allow for more
consistent and collaborative data sharing within the authority of each state statute.
Based on the investigation, recommendations were developed to facilitated information
sharing and communicated during presentations and as set forth herein. The recommendations
can be summarized as follows:
•
•
•

Develop model legislative language to enhance data sharing between and among state
MMRC abstractors;
Execute memoranda of understanding (MOUs) between states that experience barriers
to sharing relevant records with one another; and
Enhance a learning collaborative amongst the states to provide learning sessions among
state abstractors in order to:
o Support consistent strategies for abstracting;
o Share contact information and develop other forms of direct communication
between abstractors;
o Facilitate mentoring and resource development for abstractors in states where
relatively few maternal deaths may lead to inconsistent cases and practices.
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•

Update the Abstractor Manual to include more case specific examples of abstracting
strategies and learning modules for abstracting practice.

While one abstractor may not be able to help secure and produce the needed information for a
cross-border state, there are opportunities for support through provider education, contact
information, facilitated communication or even MOUs regarding action steps so that one state
can better help another even if confidential information sharing is not authorized from state to
state.
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Exhibit A: New England States’ Maternal Mortality Statute Comparison Grid: 2021
State

Cases Reviewed

New Hampshire Maternal
mortality deaths
in NH.
RSA 132:30(I)

Purpose

Identify factors
associated with the
deaths and
recommend system
changes to improve
services.
RSA 132:30(I)

Notification

Maternal mortality
deaths must be
reported by: health
care providers, health
care facilities, clinics,
laboratories, medical
records departments,
state offices, agencies
and departments.
RSA 132:31(II)

Records Reviewed

Includes, but is not
limited to: vital records;
hospital discharge data;
prenatal, fetal,
pediatric, or infant
medical records,
hospital or clinic
records, laboratory
reports, records of fetal
deaths or induced
pregnancy
terminations, and
autopsy reports.
RSA 132:31(II)

Process for Obtaining
Records

Confidentiality

The panel’s proceedings,
records, and opinions are
confidential and not subject
to RSA 91-A, discovery,
subpoena, or introduction
into evidence.
RSA 132:30(VI)(d)

Requesting Records from
other Jurisdictions

Sharing Records with
Other Jurisdictions

The same case
N/A
information may be
acquired from health
care facilities, maternal
mortality review
programs, and other
sources in other states
to ensure that its
records of New
Hampshire maternal
mortality cases are
accurate and complete.

The commissioner /
designee may retain
identifiable information
regarding facilities where
maternal deaths occur and
geographical information on RSA 132:31(II)
each case solely for the
purposes of trending and
analysis over time.
Identifiable information on
individuals and facilities shall
be removed prior to panel
case review.
RSA 132:31(III)
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State

Cases Reviewed

Purpose

Notification

Massachusetts

The commissioner
may authorize or
cause to be made
scientific studies
and research for
the purpose of the
reduction of
morbidity and
mortality within
the
commonwealth.

Reduce pregnancyassociated mortality
and morbidity.

The Registry of Vital
Records and Statistics is
responsible for
reporting all pregnancyassociated deaths to
the CDC.

MGL 111 § 24A
All pregnancyassociated deaths
in MA.
2009 Application,
“Purpose and
Rationale”

2009 Application,
“Purpose and
Rationale”

2009 Application,
“Study Design &
Analysis Plan”

Records Reviewed

Process for Obtaining
Records

Copies of hospital
N/A
medical records
(limited to hospital use
during pregnancy and
postpartum); copies of
original death
certificates and fetal
death certificates, along
with the one page
generated birth
certificate; incident
reports from the Div. of
Health Care Quality;
case information
provided by the ME’s
office; autopsy reports;
hospital inpatient
discharge, emergency
department and
observations stay data
from the Div. of Health
Care Finance & Policy
2009 Application,
“Study Design &
Analysis Plan” & “Other
Data Sources”

Confidentiality

All information, records of
interviews, written reports,
statements, notes,
memoranda, or other data
procured in connection with
such scientific studies and
research conducted by the
department or others so
authorized by the
commissioner shall be
confidential and shall be
used solely for the purposes
of medical or scientific
research.

Requesting Records from
other Jurisdictions

N/A

Sharing Records with
Other Jurisdictions

N/A

Such information, records,
reports, statements, notes,
memoranda, or other data
shall not be exhibited nor
their contents disclosed in
any way, in whole or in part,
by any officer or
representative of the
department, nor by any
other person, except as may
be necessary for the purpose
of furthering the study or
research project to which
they related. No person
participating in such an
authorized study or research
project shall disclose, in any
manner, such information so
obtained except in strict
conformity with such
research project.
MGL 111 §24A
Identifying information will
not be released.
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State

Vermont

Cases Reviewed

Maternal deaths
in Vermont
18 VSA § 1552(a)

Purpose

Notification

Records Reviewed

Identify factors
associated with
maternal deaths and
make
recommendations
for system changes
to improve health
care services for
women in this State.

Health care providers,
health care facilities,
laboratories, medical
records departments,
and State offices,
agencies and
departments shall
report all maternal
mortality deaths to the
Chair of the Maternal
Mortality Review Panel
and to the
Commissioner of Health
/ designee.

Information and
records that are
necessary and relevant
to the review of
maternal mortality.

18 VSA § 1552(a)

18 VSA § 1555(a)(1)

18 VSA § 1555(b)

Process for Obtaining
Records

In any case under
review by the Panel,
upon written
request of the
Commissioner or
designee, a person
who possesses
information or
records that are
necessary and
relevant to the
review of a maternal
mortality shall, as
soon as practicable,
provide the Panel
with the information
and records. All
requests for
information or
records by the
Commissioner or
designee related to a
case under review
shall be provided by
the person
possessing the
information or
records to the Panel
at no cost.

Confidentiality

The Panel's meetings are
confidential and shall be
exempt from the Open
Meeting Law, 1 V.S.A.
chapter 5, subchapter 2. The
records produced or
acquired by the Panel are
exempt from public
inspection and copying
under the Public Records Act
and shall be kept
confidential. The records of
the Panel are not subject to
discovery, subpoena, or
introduction into evidence in
any civil or criminal
proceeding.

Requesting Records from
other Jurisdictions

Sharing Records with
Other Jurisdictions

The Commissioner and
the Chair may acquire
the information
described in
subdivision (1) of this
subsection from health
care facilities, maternal
mortality review
programs, and other
sources in other states
to ensure that the
Panel’s records of
Vermont maternal
mortality cases are
accurate and complete.

The Department may
enter into reciprocal
agreements with
other states that have
maternal mortality
review panels
provided access under
such agreements is
consistent with
privacy, security, and
disclosure protections
in this chapter.
18 VSA § 1552(e)

18 VSA § 1555

18 VSA § 1554(a)

18 VSA § 1555(b)(1)
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State

Maine

Cases Reviewed

Purpose

Notification

Records Reviewed

Maternal, fetal
and infant deaths.

Review the deaths of
all women during
pregnancy or within
one year of giving
birth, the majority of
cases in which a fetal
death occurs after 28
weeks of gestation
and the majority of
deaths of infants.
under one year of
age.

A health care
practitioner or facility
may disclose, or when
required by law must
disclose, health care
information without
authorization to
disclose under the
circumstances stated in
this subsection.

The panel coordinator
may have access to the
death certificates of
deceased persons and
to fetal death
certificates of fetal
deaths occurring after
28 weeks of gestation.

ME ST T. 22 § 261

ME ST T. 22 § 261

The panel coordinator
may have access to
health care information
of a deceased person
and a mother of a child
who died within one
year of birth, including
fetal deaths after 28
weeks of gestation.

Disclosure may be
made without
authorization as
follows:
To a panel coordinator
of the maternal, fetal
and infant mortality
review panel pursuant
ME ST T. 22 § 261
to section 261,
subsection 4, paragraph
B-1 for the purposes of
reviewing health care
information of a
deceased person and a
mother of a child who
died within one year of
birth, including fetal
deaths after 28 weeks
of gestation.

Process for Obtaining
Records

N/A

Confidentiality

All records created or
maintained pursuant to this
section, other than reports
provided under subsection
5, paragraph B, are
protected as provided in this
subsection. The records are
confidential under section
42, subsection 5. The
records are not open to
public inspection, are not
public records for the
purposes of Title 1, chapter
13, subchapter 1 and are not
subject to subpoena or civil
process nor admissible in
evidence in connection with
any judicial, executive,
legislative or other
proceeding.

Requesting Records from
other Jurisdictions

N/A

Sharing Records with
Other Jurisdictions

N/A

ME ST T. 22 § 261

22 M.R.S.A. § 1711-C
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State

Connecticut

Cases Reviewed

There is
established,
within the
department, a
maternal
mortality review
program.

Purpose

The program shall be
responsible for
identifying maternal
death cases in
Connecticut and
reviewing medical
records and other
C.G.S.A. § 19a-59h relevant data related
to each maternal
There is
death case,
established a
including, but not
maternal
limited to,
mortality review
information
committee within collected from death
the department to and birth records,
conduct a
files from the Office
comprehensive,
of the Chief Medical
multidisciplinary
Examiner, and
review of
physician office and
maternal deaths
hospital records.
for purposes of
identifying factors C.G.S.A. § 19a-59h
associated with
To conduct a
maternal death
comprehensive,
and making
multidisciplinary
recommendations review of maternal
to reduce
deaths for purposes
maternal deaths.
of identifying factors
C.G.S.A. § 19a-59i associated with
maternal death and
making
recommendations to
reduce maternal
deaths.

Notification

Records Reviewed

Licensed health care
providers, health care
facilities and
pharmacies shall
provide the maternal
mortality review
program, established
under this section with
reasonable access to all
relevant medical
records associated with
a maternal death case
under review by the
program.

All relevant medical
records associated with
a maternal death case
under review…

C.G.S.A. § 19a-59h

including, but not
limited to, information
collected from death
and birth records, files
from the Office of the
Chief Medical
Examiner, and physician
office and hospital
records.
C.G.S.A. § 19a-59h

Process for Obtaining
Records

Confidentiality

All information, records of
interviews, written reports,
statements, notes,
memoranda or other data,
including… the maternity
mortality review committee,
established pursuant to
section 19a-59i, in
connection with studies of
morbidity and mortality
conducted by the
Department of Public
Health, such staff
committees or the maternal
mortality review committee,
or carried on by said
department, such staff
committees or the maternal
mortality review committee
jointly with other persons,
agencies or organizations, or
procured by the directors of
health of towns, cities or
boroughs or the Department
of Public Health pursuant to
section 19a-215, or procured
by such other persons,
agencies or organizations,
for the purpose of reducing
the morbidity or mortality
from any cause or condition,
shall be confidential and
shall be used solely for the
purposes of medical or
scientific research…
C.G.S.A. § 19a-25
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Requesting Records from
other Jurisdictions

Sharing Records with
Other Jurisdictions

Disclosure of
identifiable health
data (a) The
department shall not
disclose identifiable
health data unless:
…(2) The disclosure is
to health care
providers, the local
director of health, the
department, another
state or public health
agency, including
those in other states
and the federal
government, or other
persons when
deemed necessary by
the department in its
sole discretion for
disease prevention
and control pursuant
to section 19a-215 of
the Connecticut
General Statutes or
for the purpose of
reducing morbidity
and mortality from
any cause or
condition, except that
every effort shall be
made to limit the
disclosure of
identifiable health
data to the minimal
amount necessary to
accomplish the public
health purpose.
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State

Rhode Island

Cases Reviewed

Purpose

Notification

Records Reviewed

For a
multidisciplinary
maternal
mortality review
committee for
review of
maternal deaths
of women that
occur during
pregnancy,
delivery, or within
one year of the
end of pregnancy.

Reducing the
prevalence of
maternal deaths by
examining emerging
trends in such
deaths, identifying
potential
demographic,
geographic, and
structural points for
prevention, and
other factors.

This committee has the
authority to request
and receive data from
vital records,
healthcare providers,
healthcare facilities,
pharmacy records, and
any other agencies or
officials having
information that is
necessary for the
committee to carry out
its duties under this
section.

Vital records,
healthcare providers
[records], healthcare
facilities [records],
pharmacy records, and
any other agencies
[records] or officials
[records] having
information that is
necessary for the
committee to carry out
its duties under this
section.

RIGL §23-4-3
http://webserver.
rilin.state.ri.us/Sta
tutes/TITLE23/234/23-4-3.HT

This committee shall
develop
RIGL - §23-4-3
recommendations
for the prevention of
maternal deaths and
disseminate findings
and
recommendations to
policy makers,
healthcare providers,
healthcare facilities,
and the general
public.

RIGL - §23-4-3

Process for Obtaining
Records

This committee has
the authority to
request and receive
data from vital
records, healthcare
providers,
healthcare facilities,
pharmacy records,
and any other
agencies or officials
having information
that is necessary for
the committee to
carry out its duties
under this section.
RIGL - §23-4-3

Confidentiality

The work product of the
maternal mortality review
committee shall be
confidential and protected
under all applicable laws,
including the federal Health
Insurance Portability and
Accountability Act of 1996
and the Rhode Island
confidentiality of health care
information act (chapter
37.3 of title 5) and shall be
exempt from the provisions
of chapter 2 of title 38 and
shall be deemed privileged
pursuant to § 23-17.21-8;

Requesting Records from
other Jurisdictions

N/A

Sharing Records with
Other Jurisdictions

N/A

RIGL - §23-4-3

RIGL §23-4-3
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CDC, Trends in Pregnancy-related deaths in the United States: 1987-2017.
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3
https://reviewtoaction.org/
4
The CDC guidance on which cases an MMRC should review is that the state of review is the deceased individual’s
state of residence as listed on their death certificate. See
https://www.reviewtoaction.org/sites/default/files/2021-03/Reference%20Guide%20for%20PregnancyAssociated%20Death%20Identification.pdf.
5
See CDC, Trends in Pregnancy-related deaths in the United States: 1987-2017.
https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillancesystem.htm#trends
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14
U.S. Dept. of Health & Human Services, Healthy Women, Healthy Pregnancies, Healthy Futures: Action Plan to
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U.S. Dept. of Health & Human Services, Healthy Women, Healthy Pregnancies, Healthy Futures: Action Plan to
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Improve Maternal Health in America at 8 (Dec. 2020), https://aspe.hhs.gov/system/files/aspefiles/264076/healthy-women-healthy-pregnancies-healthy-future-action-plan_0.pdf; Centers for Disease Control
and Prevention, Pregnancy-related Deaths (last visited Feb. 3, 2021).
17
Aggregating many years to achieve a stable rate is not recommended because of changes in the numbers over
time as well as changes in how the deaths are classified by the MMRC. For example, the NH MMRC adoption of
published standardized criteria to determine the pregnancy-relatedness of drug-related deaths has likely
influenced classification. When deaths are classified differently over time it can be misleading to aggregate them
1
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within a single statistic. For NH’s reporting, see New Hampshire’s 2020 Annual Report on Maternal Mortality at
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